AFP and hepatocellular carcinoma: Regarding the diagnostic performance, AFP demonstrates inadequate sensitivities (41 to 65%), and specificities (80 to 94%) at a cut-off of 20 ng/mL for HCC at any stage in cirrhotic patients8.